Artículos de revistas
Diagnosis, Assessment, and Treatment of Non-Pulmonary Arterial Hypertension Pulmonary Hypertension
Fecha
2009Registro en:
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, v.54, n.1, p.S85-S96, 2009
0735-1097
10.1016/j.jacc.2009.04.008
Autor
HOEPER, Marius M.
BARBERA, Joan Albert
CHANNICK, Richard N.
HASSOUN, Paul M.
LANG, Irene M.
MANES, Alessandra
MARTINEZ, Fernando J.
NAEIJE, Robert
OLSCHEWSKI, Horst
PEPKE-ZABA, Joanna
REDFIELD, Margaret M.
ROBBINS, Ivan M.
SOUZA, Rogerio
TORBICKI, Adam
MCGOON, Michael
Institución
Resumen
The 4th World Symposium on Pulmonary Hypertension was the first international meeting to focus not only on pulmonary arterial hypertension (PAH) but also on the so-called non-PAH forms of pulmonary hypertension (PH). The term ""non-PAH PH"" summarizes those forms of PH that are found in groups 2 to 5 of the current classification of PH, that is, those forms associated with left heart disease, chronic lung disease, recurrent venous thromboembolism, and other diseases. Many of these forms of PH are much more common than PAH, but all of them have been less well studied, especially in terms of medical therapy. The working group on non-PAH PH focused mainly on 4 conditions: chronic obstructive lung disease, interstitial lung disease, chronic thromboembolic PH, and left heart disease. The medical literature regarding the role of PH in these diseases was reviewed, and recommendations regarding diagnosis and treatment of PH in these conditions are provided. Given the lack of robust clinical trials addressing PH in any of these conditions, it is important to conduct further studies to establish the role of medical therapy in non-PAH PH. (J Am Coll Cardiol 2009;54:S85-96) (C) 2009 by the American College of Cardiology Foundation